The pharmacokinetics, safety, and antiviral efficacy of taf in children and adolescent with CHB

Glossary: AASLD: American Association for the Study of Liver Diseases; ALT: Alanine aminotransferase; BMD: Bone mineral density; CHB: Chronic hepatitis B; CLCr: Creatinine clearance; HBeAg: Hepatitis B e-antigen; HBV: Hepatitis B virus; DNA: Deoxyribonucleic acid; PBO: Placebo; QD: Once a day; sCr: Serum creatinine; sPO4: Serum phophorus; TAF: Tenofovir alafenamide; TEAE: Treatment emergent adverse event; TESAE: Treatment emergent serious adverse event; ULN: Upper limit of normal

Get access to our exclusive articles.
Related Articles